Skip to main content

Table 2 Median uPA/PAI-1 levels in tumour populations

From: Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

 

uPA−/PAI-1+

uPA+/PAI-1+

uPA +/PAI-1-

uPA−/PAI-1-

Number of patients

85

92

35

135

Median level of uPA (ng/mg; min-max)

1.7 (0.19–2.9)

4.7 (3.0–12.9)

4.7 (3–7.3)

1.2 (0.0–2.9)

Median level of PAI-1 (ng/mg; min-max)

21.1 (14.0–87.8)

22.6 (14.0–130)

9.56 (5.5–13.8)

6.7 (2.9–10.6)

  1. uPA+: uPA ≥3 ng/mg; uPA-: < 3 ng/mg; PAI-1+: ≥14 ng/mg; PAI-1-: <14 ng/mg